Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course

類似資料

• Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy
  著者:: Faten Aqeel, 等
  出版事項: (2024-07-01)
• Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic
  著者:: Eric J. Gapud, 等
  出版事項: (2020-08-01)
• Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan
  著者:: John L Niles, 等
  出版事項: (2023-07-01)
• The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review
  著者:: Mohammad Amin Habibi, 等
  出版事項: (2022-12-01)
• A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
  著者:: Neveen Awad, 等
  出版事項: (2016-01-01)